More growth on the way for CSL? Australian giant in talks to buy Vifor for $7.1B - Fierce Pharma

Retrieved on: 2021-12-02 20:14:39

Tags for this article:

Click the tags to see associated articles and topics

More growth on the way for CSL? Australian giant in talks to buy Vifor for $7.1B - Fierce Pharma. View article details on hiswai:

Excerpt

CSL, unrivaled as the largest biopharma company in Australia, could grow further as it is in talks to acquire Vifor of Switzerland, a report says.

Article found on: www.fiercepharma.com